July 19, 2017 — RAD Technology Medical Systems announced their most recent project at Glendale Adventist Medical Center ...

Medic Vision, a pioneer and US market leader in 3rd party XR-29 standard solutions, announced July 19 that it was granted a patent by the U.S. Patent and Trademark Office on its XR-29 Dose-Check system (Patent No. 9693747), which is an integral part of the notable market-leading SafeCT-29 product suite.

July 18, 2017 — Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabrix ...

National Decision Support Company announced the full qualification of its CareSelect Platform as a Qualified Clinical Decision Support Mechanism (qCDSM) by the Centers for Medicare and Medicaid Services (CMS). The qualification indicates compliance with the Appropriate Use Criteria (AUC) provisions under the Protecting Access to Medicare Act (PAMA) and the Medicare Access and CHIP Reauthorization Act (MACRA).

Radiologists from Synergy Radiology Associates (SRA) in Houston are using the power of 3-D medical imaging and subspecialty radiology to provide better patient care for men with suspicious prostate cancer findings.

Ionizing radiation, such as X-rays, has a harmful effect on the cardiovascular system even at doses equivalent to recurrent computed tomography (CT) imaging, a new study published in the International Journal of Radiation Biology suggests.

The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of contrast media.

In a series of proposed rule changes to the Medicare Physician Fee Schedule (MPFS) released July 13, the Centers for Medicare and Medicaid Services (CMS) pushed back the start date for when providers will be required to consult clinical decision support (CDS) for advanced diagnostic imaging to 2019. CMS indicated the first year would be considered an “educational and operational testing year,” meaning claims would still be paid on advanced diagnostic imaging services that do not indicate appropriate use criteria (AUC) were consulted.

Elekta and Sunnybrook Health Sciences Centre have initiated installation of Elekta’s MR-linac, an investigational magnetic resonance radiation therapy (MR/RT) system at the Odette Cancer Centre, Sunnybrook Health Sciences Centre in Toronto.